Glossary

Proprietary Blend

Updated February 28, 2026

Proprietary blends hide ingredient-level dose detail, which reduces transparency for both safety and optimization decisions.

Why it matters

Without per-ingredient grams, duplicate detection and interaction screening become less precise.

Transparency tradeoff

Lower label transparency means lower confidence around:

• true active dose per ingredient
• contamination or substitution risk
• stacking math with overlapping compounds

Impact on safety checks

Safety systems may keep more conservative ceilings when proprietary blends are used because exact overlap cannot be confirmed.

Practical action rule

Avoid proprietary blends when you need clinical tracking or symptom attribution.

If you already use one, log it as a single high-uncertainty unit and reduce simultaneous overlap with related ingredients.

Uncertainty and limits

• Evidence is limited on ingredient-level effects for most proprietary blends in controlled settings.
• Evidence is limited on long-term outcome reliability when dosage transparency is absent.

Cross-site references

• Ingredient label
• Duplicate ingredient risk
• Recommendation confidence

How this appears in Unfair

The platform may apply stricter duplicate and interaction assumptions and reduce ranking confidence for proprietary blends.

Clinical safety note

Treat proprietary blends as high-uncertainty sources and prefer clinician-guided oversight for complex or high-risk stacks.